Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Industry Landscape

Articles under this category focus on macro trends, big pharma behavior, and annual outlooks.

HOW PHARMA REPS CAN USE PREDICTIVE ANALYSIS FOR HIGH- VALUE CALLS PREDICTIVE ANALYTICS PHARMA SALES.
Posted in
  • Industry Landscape
  • Strategy & Execution

HOW PHARMA REPS CAN USE PREDICTIVE ANALYSIS FOR HIGH- VALUE CALLS PREDICTIVE ANALYTICS PHARMA SALES.

Targeting Smarter, Not Harder In 2024, U.S. pharmaceutical sales representatives spend over 40% of their field … HOW PHARMA REPS CAN USE PREDICTIVE ANALYSIS FOR HIGH- VALUE CALLS PREDICTIVE ANALYTICS PHARMA SALES.Read more

by Jayshree Gondane•December 2, 2025December 3, 2025•0
AI-Enhanced Sales Forecasting for Niche Therapeutics: Transforming U.S. Pharma Strategy in 2025
Posted in
  • Industry Landscape

AI-Enhanced Sales Forecasting for Niche Therapeutics: Transforming U.S. Pharma Strategy in 2025

The Stakes in Niche Therapeutics Niche therapeutics represent a rapidly growing segment of U.S. pharmaceutical sales. … AI-Enhanced Sales Forecasting for Niche Therapeutics: Transforming U.S. Pharma Strategy in 2025Read more

by Jayshree Gondane•December 2, 2025December 2, 2025•0
Novo Nordisk Rises to the Global Top Five as Ozempic and Wegovy Redefine Obesity Care
Posted in
  • Case Studies & Trends
  • Industry Landscape
  • Uncategorized

Novo Nordisk Rises to the Global Top Five as Ozempic and Wegovy Redefine Obesity Care

You can track shifts in global healthcare by watching where capital flows, how prescribers modify their … Novo Nordisk Rises to the Global Top Five as Ozempic and Wegovy Redefine Obesity CareRead more

by Gurinder Khera•November 19, 2025November 19, 2025•0
How Johnson & Johnson Maintains Its Fourth-Place Global Position as Oncology and Immunology Drive Growth Against Biosimilar Pressures
Posted in
  • Case Studies & Trends
  • Industry Landscape

How Johnson & Johnson Maintains Its Fourth-Place Global Position as Oncology and Immunology Drive Growth Against Biosimilar Pressures

Leadership in biopharma demands the ability to build new revenue engines while older franchises decline. Many … How Johnson & Johnson Maintains Its Fourth-Place Global Position as Oncology and Immunology Drive Growth Against Biosimilar PressuresRead more

by Gurinder Khera•November 19, 2025November 19, 2025•0
Eli Lilly Surges to Third in 2025 Rankings Fueled by Explosive GLP-1 Demand for Mounjaro and Zepbound
Posted in
  • Case Studies & Trends
  • Industry Landscape

Eli Lilly Surges to Third in 2025 Rankings Fueled by Explosive GLP-1 Demand for Mounjaro and Zepbound

Eli Lilly’s ascent in 2025 is not the outcome of hype, nor is it a temporary … Eli Lilly Surges to Third in 2025 Rankings Fueled by Explosive GLP-1 Demand for Mounjaro and ZepboundRead more

by Gurinder Khera•November 19, 2025November 19, 2025•0
Merck & Co. Secures Second Place as Keytruda Drives Record Oncology Revenues in 2025
Posted in
  • Case Studies & Trends
  • Industry Landscape

Merck & Co. Secures Second Place as Keytruda Drives Record Oncology Revenues in 2025

Pharma analysts spend years tracking patterns in drug launches, oncology pipelines, and market cycles. You rarely … Merck & Co. Secures Second Place as Keytruda Drives Record Oncology Revenues in 2025Read more

by Gurinder Khera•November 19, 2025November 19, 2025•0
Roche Retains Top Spot in Global Pharma Sales for 2025 Amid Steady Growth from a Diverse Portfolio
Posted in
  • Industry Landscape

Roche Retains Top Spot in Global Pharma Sales for 2025 Amid Steady Growth from a Diverse Portfolio

Market cycles shift. Pipelines rise and fall. Investor sentiment swings on every quarterly update. Yet something … Roche Retains Top Spot in Global Pharma Sales for 2025 Amid Steady Growth from a Diverse PortfolioRead more

by Gurinder Khera•November 19, 2025November 19, 2025•0
10 Most Impactful Changes Shaping the Pharma and Biotech Industry in 2025
Posted in
  • Industry Landscape

10 Most Impactful Changes Shaping the Pharma and Biotech Industry in 2025

If you work in pharma or biotech today, you’re facing a year defined by velocity. Every … 10 Most Impactful Changes Shaping the Pharma and Biotech Industry in 2025Read more

by Gurinder Khera•November 17, 2025November 17, 2025•0
Biopharma Layoffs: Optimizing Sales Teams Amid Workforce Shifts
Posted in
  • Industry Landscape
  • Job & Career

Biopharma Layoffs: Optimizing Sales Teams Amid Workforce Shifts

You open your laptop on a Monday morning and see yet another press release from a … Biopharma Layoffs: Optimizing Sales Teams Amid Workforce ShiftsRead more

by Gurinder Khera•November 7, 2025November 7, 2025•0
Competitive Intelligence Surge: Elevating Pharma Marketing Insights
Posted in
  • Digital Transformation
  • Industry Landscape

Competitive Intelligence Surge: Elevating Pharma Marketing Insights

You’re sitting in a conference room, reviewing your product launch plan, when your competitor announces positive … Competitive Intelligence Surge: Elevating Pharma Marketing InsightsRead more

by Gurinder Khera•November 7, 2025November 7, 2025•0

Posts pagination

Previous 1 … 11 12 13 … 18 Next

Recent Posts

  • How to Handle Price Objections in Pharma Sales
  • Remote Pharmaceutical Sales: Complete Guide
  • How to Navigate Group Purchasing Organizations (GPOs)
  • Selling Specialty Pharmaceuticals vs. Primary Care
  • How to Use Clinical Data in Sales Presentations

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A